US Stock MarketDetailed Quotes

VYNE VYNE Therapeutics

Watchlist
  • 1.7000
  • -0.0800-4.49%
Close Mar 28 16:00 ET
  • 1.6900
  • -0.0100-0.59%
Post 16:37 ET
25.86MMarket Cap-1.83P/E (TTM)

VYNE Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-34.06%-33.97M
-75.18%-9M
-65.18%-8.51M
11.42%-8.48M
-45.71%-7.98M
13.22%-25.34M
-6.78%-5.14M
27.69%-5.15M
-16.40%-9.57M
39.40%-5.48M
Net income from continuing operations
-40.00%-39.83M
-94.28%-12.02M
-84.64%-12.16M
6.48%-9.41M
-11.15%-6.25M
-22.59%-28.45M
37.78%-6.19M
30.39%-6.58M
-18.66%-10.06M
-220.39%-5.62M
Depreciation and amortization
--4K
----
----
----
----
--0
----
----
----
----
Change In working capital
8,231.67%5M
381.51%2.87M
500.70%3.42M
267.35%656K
-172.47%-1.94M
-97.36%60K
-84.91%595K
-40.11%569K
59.34%-392K
56.87%-712K
-Change in receivables
-321.98%-899K
212.42%688K
415.65%2.54M
-490.34%-2.83M
-547.00%-1.29M
-96.39%405K
-119.35%-612K
394.61%492K
213.85%725K
-102.51%-200K
-Change in payables and accrued expense
1,175.49%6.01M
121.55%2.2M
1,072.73%903K
415.22%3.52M
-19.53%-612K
93.56%-559K
-60.61%993K
-25.96%77K
34.53%-1.12M
94.67%-512K
-Change in other current liabilities
-153.27%-114K
-110.75%-23K
---22K
---35K
---34K
161.32%214K
--214K
--0
--0
--0
Cash from discontinued investing activities
Operating cash flow
-34.06%-33.97M
-75.18%-9M
-65.18%-8.51M
11.42%-8.48M
-45.71%-7.98M
13.22%-25.34M
-6.78%-5.14M
27.69%-5.15M
-16.40%-9.57M
39.40%-5.48M
Investing cash flow
Cash flow from continuing investing activities
140.74%23.37M
120.43%12.74M
-4.82M
19.02M
-171.38%-3.57M
-466.08%-57.35M
-6,235,500.00%-62.35M
0
0
-68.26%5M
Net PPE purchase and sale
---117K
----
----
----
----
--0
----
----
----
----
Net business purchase and sale
--0
--0
--0
--0
--0
-68.09%5M
--0
--0
--0
-68.26%5M
Net investment purchase and sale
137.66%23.48M
120.62%12.86M
---4.82M
--19.02M
---3.57M
---62.35M
---62.35M
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
140.74%23.37M
120.43%12.74M
---4.82M
--19.02M
-171.38%-3.57M
-466.08%-57.35M
-6,235,500.00%-62.35M
--0
--0
-68.26%5M
Financing cash flow
Cash flow from continuing financing activities
-100.17%-141K
-100.16%-132K
95.74%-2K
40.00%-3K
98.16%-4K
4,884.51%82.39M
39,641.83%82.66M
-80.77%-47K
91.80%-5K
-114.16%-217K
Net common stock issuance
--0
--0
--0
--0
--0
5,534.08%82.82M
8,266,600.00%82.67M
--0
--0
-89.98%156K
Net preferred stock issuance
--0
--0
--0
--0
--0
-270.62%-360K
--0
--0
--0
---360K
Proceeds from stock option exercised by employees
-110.45%-141K
----
----
40.00%-3K
69.23%-4K
-139.29%-67K
----
----
---5K
---13K
Cash from discontinued financing activities
Financing cash flow
-100.17%-141K
-100.16%-132K
95.74%-2K
40.00%-3K
98.16%-4K
4,884.51%82.39M
39,641.83%82.66M
-80.77%-47K
91.80%-5K
-114.16%-217K
Net cash flow
Beginning cash position
-0.97%30.67M
5.27%16.32M
43.25%29.66M
-36.86%19.12M
-0.97%30.67M
-27.72%30.98M
-56.43%15.5M
-51.65%20.7M
-40.74%30.28M
-27.72%30.98M
Current changes in cash
-3,470.76%-10.75M
-76.23%3.61M
-156.51%-13.34M
209.99%10.54M
-1,562.59%-11.56M
97.47%-301K
429.68%15.17M
28.16%-5.2M
-15.60%-9.58M
-108.43%-695K
End cash Position
-35.04%19.93M
-35.04%19.93M
5.27%16.32M
43.25%29.66M
-36.86%19.12M
-0.97%30.67M
-0.97%30.67M
-56.43%15.5M
-51.65%20.7M
-40.74%30.28M
Free cash flow
-34.52%-34.09M
-77.46%-9.12M
-65.18%-8.51M
11.42%-8.48M
-45.71%-7.98M
13.22%-25.34M
-6.78%-5.14M
27.69%-5.15M
-16.40%-9.57M
39.40%-5.48M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -34.06%-33.97M-75.18%-9M-65.18%-8.51M11.42%-8.48M-45.71%-7.98M13.22%-25.34M-6.78%-5.14M27.69%-5.15M-16.40%-9.57M39.40%-5.48M
Net income from continuing operations -40.00%-39.83M-94.28%-12.02M-84.64%-12.16M6.48%-9.41M-11.15%-6.25M-22.59%-28.45M37.78%-6.19M30.39%-6.58M-18.66%-10.06M-220.39%-5.62M
Depreciation and amortization --4K------------------0----------------
Change In working capital 8,231.67%5M381.51%2.87M500.70%3.42M267.35%656K-172.47%-1.94M-97.36%60K-84.91%595K-40.11%569K59.34%-392K56.87%-712K
-Change in receivables -321.98%-899K212.42%688K415.65%2.54M-490.34%-2.83M-547.00%-1.29M-96.39%405K-119.35%-612K394.61%492K213.85%725K-102.51%-200K
-Change in payables and accrued expense 1,175.49%6.01M121.55%2.2M1,072.73%903K415.22%3.52M-19.53%-612K93.56%-559K-60.61%993K-25.96%77K34.53%-1.12M94.67%-512K
-Change in other current liabilities -153.27%-114K-110.75%-23K---22K---35K---34K161.32%214K--214K--0--0--0
Cash from discontinued investing activities
Operating cash flow -34.06%-33.97M-75.18%-9M-65.18%-8.51M11.42%-8.48M-45.71%-7.98M13.22%-25.34M-6.78%-5.14M27.69%-5.15M-16.40%-9.57M39.40%-5.48M
Investing cash flow
Cash flow from continuing investing activities 140.74%23.37M120.43%12.74M-4.82M19.02M-171.38%-3.57M-466.08%-57.35M-6,235,500.00%-62.35M00-68.26%5M
Net PPE purchase and sale ---117K------------------0----------------
Net business purchase and sale --0--0--0--0--0-68.09%5M--0--0--0-68.26%5M
Net investment purchase and sale 137.66%23.48M120.62%12.86M---4.82M--19.02M---3.57M---62.35M---62.35M--0--0--0
Cash from discontinued investing activities
Investing cash flow 140.74%23.37M120.43%12.74M---4.82M--19.02M-171.38%-3.57M-466.08%-57.35M-6,235,500.00%-62.35M--0--0-68.26%5M
Financing cash flow
Cash flow from continuing financing activities -100.17%-141K-100.16%-132K95.74%-2K40.00%-3K98.16%-4K4,884.51%82.39M39,641.83%82.66M-80.77%-47K91.80%-5K-114.16%-217K
Net common stock issuance --0--0--0--0--05,534.08%82.82M8,266,600.00%82.67M--0--0-89.98%156K
Net preferred stock issuance --0--0--0--0--0-270.62%-360K--0--0--0---360K
Proceeds from stock option exercised by employees -110.45%-141K--------40.00%-3K69.23%-4K-139.29%-67K-----------5K---13K
Cash from discontinued financing activities
Financing cash flow -100.17%-141K-100.16%-132K95.74%-2K40.00%-3K98.16%-4K4,884.51%82.39M39,641.83%82.66M-80.77%-47K91.80%-5K-114.16%-217K
Net cash flow
Beginning cash position -0.97%30.67M5.27%16.32M43.25%29.66M-36.86%19.12M-0.97%30.67M-27.72%30.98M-56.43%15.5M-51.65%20.7M-40.74%30.28M-27.72%30.98M
Current changes in cash -3,470.76%-10.75M-76.23%3.61M-156.51%-13.34M209.99%10.54M-1,562.59%-11.56M97.47%-301K429.68%15.17M28.16%-5.2M-15.60%-9.58M-108.43%-695K
End cash Position -35.04%19.93M-35.04%19.93M5.27%16.32M43.25%29.66M-36.86%19.12M-0.97%30.67M-0.97%30.67M-56.43%15.5M-51.65%20.7M-40.74%30.28M
Free cash flow -34.52%-34.09M-77.46%-9.12M-65.18%-8.51M11.42%-8.48M-45.71%-7.98M13.22%-25.34M-6.78%-5.14M27.69%-5.15M-16.40%-9.57M39.40%-5.48M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Symbol Mini Chart % Chg
The Kroger Co.
KR
+0.88%
The Kraft Heinz
KHC
+0.57%
Chevron
CVX
-0.34%
Coca-Cola
KO
-0.52%
Chubb Ltd
CB
-0.64%

Unlock the Full List